News
HDA UK Media And Political Bulletin – 27 September 2017
|
Media Summary |
| BGMA: We are working with Department of Health to counter generic shortages
Pharmacy Business, Neil Trainis, 26 September 2017
Pharmacy Business highlights the BGMA assurances to community pharmacists that it is working with the Department of Health to find solutions to the generic shortages. Many community pharmacists have struggled to source products in the wake of the generic drug shortages and the BGMA has reported that it is working with the DoH to find solutions and ensure that “any impact on patients is kept to an absolute minimum.”
|
|
Parliamentary Coverage |
|
There is no Parliamentary coverage today.
|
|
Full Coverage |
|
BGMA: We are working with Department of Health to counter generic shortages Pharmacy Business, Neil Trainis, 26 September 2017
The British Generic Manufacturers Association has reassured community pharmacists who have struggled to source products in the wake of generic drug shortages that its members are working with the Department of Health to find solutions and ensure “any impact on patients is kept to an absolute minimum.”
The PSNC said last week it was in “urgent” talks with the DoH over “price concessions and wider concerns” following reports that contractors were enduring a shortage of generic drugs from Bristol Laboratories and Dr. Reddy’s.
When asked if he was aware of generic shortages at Bristol Labs and Dr. Reddy’s or any other of its members, BGMA director general Warwick Smith (pictured) told Pharmacy Business: “A regulatory issue is currently limiting the supply of some medicines.
“The industry is working with the Department of Health to identify alternative sources of supply so that any impact on patients is kept to an absolute minimum.
“Due to the multi-source nature of the UK generics market, when occasional supply issues of this kind arise, other manufacturers are usually able to increase production to mitigate any potential supply shortfall. Our focus and priority is on quality and security of supply.”
Rajiv Shah, a director at Sigma Pharmaceuticals, told the Avicenna conference in northern Cyprus in 2015 that generic drug shortages were costing independent pharmacists in England £10 million a year. |
